232 related articles for article (PubMed ID: 24423350)
21. Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?
Morelli V; Ghielmetti A; Caldiroli A; Grassi S; Siri FM; Caletti E; Mucci F; Aresta C; Passeri E; Pugliese F; Di Giorgio A; Corbetta S; Scillitani A; Arosio M; Buoli M; Chiodini I
J Clin Endocrinol Metab; 2021 Jan; 106(1):e130-e139. PubMed ID: 33017843
[TBL] [Abstract][Full Text] [Related]
22. Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma.
Oki K; Yamane K; Nakanishi S; Shiwa T; Kohno N
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):244-7. PubMed ID: 22328110
[TBL] [Abstract][Full Text] [Related]
23. Adrenal incidentaloma, a five year experience.
Terzolo M; Osella G; Alì A; Reimondo G; Borretta G; Magro GP; Luceri S; Paccotti P; Angeli A
Minerva Endocrinol; 1995 Mar; 20(1):69-78. PubMed ID: 7651285
[TBL] [Abstract][Full Text] [Related]
24. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.
Mantero F; Terzolo M; Arnaldi G; Osella G; Masini AM; Alì A; Giovagnetti M; Opocher G; Angeli A
J Clin Endocrinol Metab; 2000 Feb; 85(2):637-44. PubMed ID: 10690869
[TBL] [Abstract][Full Text] [Related]
25. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.
Chiodini I; Torlontano M; Scillitani A; Arosio M; Bacci S; Di Lembo S; Epaminonda P; Augello G; Enrini R; Ambrosi B; Adda G; Trischitta V
Eur J Endocrinol; 2005 Dec; 153(6):837-44. PubMed ID: 16322389
[TBL] [Abstract][Full Text] [Related]
26. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
[TBL] [Abstract][Full Text] [Related]
27. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
28. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
29. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
Morelli V; Polledri E; Mercadante R; Zhukouskaya V; Palmieri S; Beck-Peccoz P; Spada A; Fustinoni S; Chiodini I
Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
[TBL] [Abstract][Full Text] [Related]
30. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
Yener S; Baris M; Peker A; Demir O; Ozgen B; Secil M
Clin Endocrinol (Oxf); 2017 Nov; 87(5):425-432. PubMed ID: 28656620
[TBL] [Abstract][Full Text] [Related]
31. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
[TBL] [Abstract][Full Text] [Related]
32. Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass.
Donadio F; Morelli V; Salcuni AS; Eller-Vainicher C; Carletto M; Castellani M; Dellavedova L; Scillitani A; Beck-Peccoz P; Chiodini I
J Endocrinol Invest; 2009 Jul; 32(7):576-80. PubMed ID: 19535891
[TBL] [Abstract][Full Text] [Related]
33. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
Patrova J; Kjellman M; Wahrenberg H; Falhammar H
Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
[TBL] [Abstract][Full Text] [Related]
34. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
Favero V; Aresta C; Parazzoli C; Cairoli E; Eller-Vainicher C; Palmieri S; Salcuni AS; Arosio M; Persani L; Scillitani A; Morelli V; Chiodini I
Cardiovasc Diabetol; 2023 May; 22(1):102. PubMed ID: 37131218
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
[TBL] [Abstract][Full Text] [Related]
36. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
37. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
Morelli V; Palmieri S; Lania A; Tresoldi A; Corbetta S; Cairoli E; Eller-Vainicher C; Arosio M; Copetti M; Grossi E; Chiodini I
Eur J Endocrinol; 2017 Jul; 177(1):73-83. PubMed ID: 28468767
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
40. Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma.
Toini A; Dolci A; Ferrante E; Verrua E; Malchiodi E; Sala E; Lania AG; Chiodini I; Beck-Peccoz P; Arosio M; Spada A; Mantovani G
Eur J Endocrinol; 2015 Apr; 172(4):363-9. PubMed ID: 25722096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
